MarketInOut Stock Screener Log In | Sign Up

Guangzhou Innogen Pharmaceutical Group Co Ltd

HKSE • Healthcare • Biotechnology • Quote as of 10/30/2026
Guangzhou Innogen Pharmaceutical Group Co Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeHKSE
Market Capitalization1,493.8 mln
Float79.61 mln
Earnings Date03/23/2027

Piotroski F-Score

4 / 9
Borderline

1-Year Forecast

20.68
Transformational upside

Relative Strength

33 / 100
Underperforming

Debt / Equity

0.16
Very low leverage

Pre-Tax Margin

-217%
Severely loss-making

ROE

-37.00
Deeply negative

Business Description

Founded a decade ago and headquartered in Shanghai, Innogen Pharmaceutical is a Chinese drug maker focused on bringing new treatments to patients suffering from conditions such as diabetes, obesity, and liver disease, as well as disorders of the brain and nervous system. The company handles everything from early-stage research through to bringing finished medicines to market.

Key Fundamentals

EPS-0.90
ROE-37.00
RPS0.39
ROIC-130
ROA-26.02
Interest Cover-87.08
EBITDA, mln-352
EV / EBITDA-1.37
EV / EBIT-1.31
Revenue, mln171
EV / Revenue2.81

Quote Details

Last 3.40
Change 0.13 (3.98%)
Open 3.30
Volume 51,029,400
Turnover 173,499,968
Average Volume 6,246,332

Financial Ratios

Pre-Tax Profit Margin-217
Leverage Ratio1.38
Current Ratio3.50
Price / Book1.37
Price / Tangible Book1.40
Debt / Equity0.16
Price / Sales8.70

Financial Strength

Altman Z-Score0.03
Piotroski F-Score 4 / 9
1-Year Target Price20.68

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 3.66% 83 / 100   
1 Month -10.05% 40 / 100   
2 Months -55.2% 3 / 100   
6 Months -79.24% 2 / 100   
1 Year -90.14% 1 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog